T cells adapt to persist in the long fight against cancer and chronic infection
A new perspective published in Cellular & Molecular Immunology explores the critical process of T cell adaptation in the context of chronic infections and tumors. The article synthesizes current understanding of how T cells, central players in adaptive immunity, undergo functional and metabolic reprogramming to survive in hostile, long-term inflammatory environments. This adaptation is a double-edged sword; while it allows for sustained immune surveillance, it can also lead to a state of dysfunction known as T cell exhaustion, which impairs the immune system’s ability to clear persistent pathogens or eliminate malignant cells. The briefing delves into the underlying molecular mechanisms, including shifts in cytokine signaling, epigenetic modifications, and changes in metabolic pathways that define this adaptive state. Understanding these processes is pivotal for developing next-generation immunotherapies aimed at reversing exhaustion and enhancing T cell-mediated immunity.
Study Significance: For immunologists and clinical researchers, this work provides a crucial framework for understanding immune evasion in chronic disease. It directly informs the development of strategies to modulate T cell function, which is central to improving outcomes in cancer immunotherapy and managing persistent viral infections. The insights into clonal expansion and immune memory under sustained antigen exposure can guide the design of more effective vaccines and adoptive cell therapies like CAR-T cells.
Source →Stay curious. Stay informed — with Science Briefing.
This is a one time Briefing, Upgrade to continue.
